Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Vir Biotechnology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VIR.
You can purchase shares of Vir Biotechnology (NASDAQ:VIR) through any online brokerage.
Other companies in Vir Biotechnology’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Syndax Pharmaceuticals (NASDAQ:SNDX) and Replimune Group (NASDAQ:REPL).
Vir Biotechnology has a consensus price target of $31.55.
The stock price for Vir Biotechnology (NASDAQ: VIR) is $7.2 last updated March 24, 2025 at 4:00 PM EDT.
There are no upcoming dividends for Vir Biotechnology.
Vir Biotechnology’s Q1 earnings are confirmed for Thursday, May 1, 2025.
There is no upcoming split for Vir Biotechnology.
Vir Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.